ABIOMED INC·4

Feb 3, 5:03 PM ET

PUHY DOROTHY E 4

4 · ABIOMED INC · Filed Feb 3, 2021

Insider Transaction Report

Form 4
Period: 2021-02-01
Transactions
  • Sale

    Common Stock, $0.01 par value

    2021-02-01$345.64/sh1,846$638,0516,023 total
  • Sale

    Common Stock, $0.01 par value

    2021-02-01$351.97/sh1,304$458,9693,070 total
  • Sale

    Common Stock, $0.01 par value

    2021-02-01$351.34/sh1,649$579,3604,374 total
  • Sale

    Common Stock, $0.01 par value

    2021-02-01$353.07/sh201$70,9672,869 total
Holdings
  • Common Stock, $0.01 par value

    (indirect: By Trust)
    11,335
Footnotes (5)
  • [F1]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  • [F2]This price represents the sale price of the transactions on the reported date at $345.6400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F3]This price represents the sale price of the transactions on the reported date at $351.3364. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F4]This price represents the sale price of the transactions on the reported date at $351.9665. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  • [F5]This price represents the sale price of the transactions on the reported date at $353.0736. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Documents

2 files